Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Patient with Leiden V Mutation, Multiple Sclerosis, Psoriasis, and Sicca Syndrome: Could Celecoxib and Fingolimod Adversely Affect the Heart?
In vivo vs. ex vivo Magnetic Resonance Imaging In Mice.
B-Cell Depletion Abrogates T Cell-Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model.
Self-Reported Fatigue and Energy Cost During Walking Are Not Related in Patients With Multiple Sclerosis.
Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
Pathophysiology of the brain extracellular matrix: a new target for remyelination.
Natalizumab in relapsing-remitting multiple sclerosis.
Back on the scent: the olfactory system in CNS demyelinating diseases.
The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
Cyclophosphamide therapy in pediatric multiple sclerosis.
Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy.
Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
The pathology of multiple sclerosis.
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.
FTY720 mediates activation suppression and G(0)/G (1) cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model.
Ustekinumab approved for psoriatic arthritis in US, Europe
Progressive multifocal leukoencephalopathy: new concepts.
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up.
Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
Th17 Cells in Neuromyelitis Optica Spectrum Disorder: A review.
Longitudinal extensive transverse myelitis and optic neuritis: the elements for the diagnosis of neuromyelitis optica.
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc.
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
Pages
« first
‹ previous
…
197
198
199
200
201
202
203
204
205
…
next ›
last »